Newsroom

LONDON--(BUSINESS WIRE)--  Funds Date TIDM ISIN Code Shares in Issue Currency Net Asset Value NAV/per Share First Trust Nasdaq Clean Edge Global Water UCITS ETF 12.08.2026 H2O LN IE000Q8F0M81  600,002.00 USD  12,538,277.67   20.897  ...

LONDON--(BUSINESS WIRE)--  FORM 8.3 PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE Rule 8.3 of the Takeover Code (the “Code”) 1. KEY INFORMATION (a) Full name of discloser: Qube Research & Technologies Limited (b) Owner or controller of interests and short positions disclosed, if different from 1(a): The naming of nominee or vehicle companies is insufficient. For a trust, the trustee(s), settlor and beneficiari...

ORLANDO, Fla.--(BUSINESS WIRE)--Falcon’s Beyond Global, Inc. (Nasdaq: FBYD) (“Falcon’s Beyond”, “Falcon’s” or the “Company”), a visionary entertainment and technology enterprise through its three complementary business divisions Falcon’s Creative Group (“FCG”), Falcon’s Beyond Brands (“FBB”), and Falcon’s Beyond Destinations (“FBD”) reported financial results for the second quarter 2026. Second Quarter 2026 Highlights Revenue Falcon's generated consolidated revenue of $5.6 million for the three...

FORT LAUDERDALE, Fla.--(BUSINESS WIRE)--Auxis, a leading business modernization and nearshore outsourcing pioneer and part of Grant Thornton Advisors LLC and its multinational platform, today announced the opening of a new global outsourcing center in Bogotá, Colombia. The move expands Auxis’ Latin American delivery network and its capacity to meet rising demand for nearshore talent, AI-enabled transformation and increasingly complex business operations support. Located in one of Latin America’...

LONDON--(BUSINESS WIRE)--  FORM 8.3 PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE Rule 8.3 of the Takeover Code (the “Code”) 1. KEY INFORMATION (a) Full name of discloser: Qube Research & Technologies Limited (b) Owner or controller of interests and short positions disclosed, if different from 1(a): The naming of nominee or vehicle companies is insufficient. For a trust, the trustee(s), settlor and beneficiari...

LONDON--(BUSINESS WIRE)--  11-August-2026 Issue: Newday Funding Master Issuer Plc Series 2024-1 Class F RegS XS2768183688 Pursuant to our appointment as Agent for the above stated issue, please be advised of the following interest rate determination: Date From: 15-July-2026 Date To: 17-August-2026 Record Date: 14-August-2026 Value Date: 17-August-2026 Benchmark Rate: 3.73706% Margin: 5.8% Total Rate: 9.53706% Number of Days: 33 Day Count: Actual / 365L Interest Frequency: Monthly Total Amount D...

LONDON--(BUSINESS WIRE)--  FORM 8.3 PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE Rule 8.3 of the Takeover Code (the “Code”) 1. KEY INFORMATION (a) Full name of discloser: Qube Research & Technologies Limited (b) Owner or controller of interests and short positions disclosed, if different from 1(a): The naming of nominee or vehicle companies is insufficient. For a trust, the trustee(s), settlor and beneficiari...

LONDON--(BUSINESS WIRE)--  FORM 8.3 PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE Rule 8.3 of the Takeover Code (the “Code”) 1. KEY INFORMATION (a) Full name of discloser: Qube Research & Technologies Limited (b) Owner or controller of interests and short positions disclosed, if different from 1(a): The naming of nominee or vehicle companies is insufficient. For a trust, the trustee(s), settlor and beneficiari...

ZUG, Switzerland--(BUSINESS WIRE)--Swiss FINMA-regulated bank expands digital asset offering to include Hyperliquid's native token as more regulated entry points into HYPE emerge...

TORONTO--(BUSINESS WIRE)--NeuPath Health Inc. (TSXV:NPTH), (“NeuPath” or the “Company”) operates one of Canada’s largest networks of community-based, multidisciplinary medical facilities focused on the assessment and treatment of chronic pain, musculoskeletal/back pain, sports medicine and other pain-related medical services, today announced its financial and operating results for the three and six months ended June 30, 2026 and information regarding the Company’s investor webinar on Thursday,...